For the first time since 2003, the United States has approved a new drug to treat Alzheimer’s
The US Food and Drug Administration (FDA) has approved the use of the Alzheimer’s drug aducanumab for the first time since 2003.
Alzheimer’s is an incurable mental illness that affects people’s memory. Millions of people around the world suffer from Alzheimer’s, which is considered incurable.
According to Alzheimer’s Disease International, the number of Alzheimer’s / dementia patients is increasing every 3 seconds.
According to a foreign news agency, the test drug used in the early stages of Alzheimer’s has been approved today, after which the way for its use in the UK will be paved.
According to reports, the US Food and Drug Administration has not approved any drug to treat Alzheimer’s since 2003.
According to the FDA, there is evidence that the drug will significantly benefit Alzheimer’s patients and hope for better results in the future.